Cochlear Limited (COH.AX) Stock Analysis & Winston Score

Cochlear Limited is an Australian medical device company that makes hearing implants for people who are deaf or have severe hearing loss. Its main products are cochlear implants — small electronic devices surgically placed inside the ear — along with bone-anchored hearing systems and acoustic implants. The company sells to hospitals, surgeons, and patients across more than 100 countries, and it is the world's largest manufacturer of cochlear implants. Cochlear makes money by selling implant hardware upfront and then selling sound processor upgrades to existing recipients over time, creating a recurring revenue stream from its installed base of over 700,000 users worldwide. It operates globally, with strong positions in North America, Europe, and Asia-Pacific, and its moat comes from decades of clinical data, surgeon relationships, and the fact that patients rarely switch brands once implanted. The key growth driver is the large number of people with hearing loss who remain undiagnosed or untreated, though currency fluctuations and the high cost of its devices in emerging markets are ongoing risks.